Evaluation of the Impact of the Administration of Single Dose of Ivermectin in the Early Phase of COVID-19

Clinical trial NCT05040724 · UNKNOWN

Trial details

NCT number: NCT05040724
Sponsor: Raincy Montfermeil Hospital Group
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

To Assess the Reduction in the Viral Load of SARS-CoV-2 in Patients Receiving Ivermectin Compared to Those Receiving Standard Care

Start date: 2021-05-28
Primary completion: 2022-05-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.